×

Warning

JUser: :_load: Unable to load user with ID: 172

Questions? Call us at +45 25 32 17 73

Menu

News

In our news section, you will find an overview and content of events Anapa Biotech have attended or will be attending as well as publications, posters, presentations and press releases distributed by Anapa Biotech.

 

  • Published in Events

Meet us at the Bio-Europe Spring meeting in Amsterdam

Anapa Biotech will be present at the Bio-Europe Spring partnering event in Amsterdam. Contact us if you wish to learn more about our MeltPlex multiplex PCR method and how it might help broaden your diagnostic testing panels

MELTPLEX IS A NEW PCR MULTIPLEXING METHOD 

Anapa Biotech has developed the MeltPlex® technology that utilizes a system of labelled Taqman-type probes allowing each to be read out by subsequent melting curve analysis. 5 or more probes can now be analyzed per fluorophore channel totaling more than 20 targets per single tube.

Despite the developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to the lack of sufficient detection channels. This promted the development of MeltPlex®, which expands the multiplexing limits of PCR diagnostics.

“With MeltPlex®, we enable considerably more answers per sample as well as more cost-efficient diagnostic processing,” says Søren Morgenthaler Echwald, CEO of Anapa Biotech and adds “In particular, with MeltPlex® we are opening new opportunities for design of syndromic PCR panels covering up to 20 or more pathogens, on the existing installed base of both stand-alone and sample-to-result real-time PCR instruments."

MeltPlex® reaction and melting analysis is performed without the need to re-open PCR reaction tubes. By utilizing melting curve readout of modified probes – one for each target - rather than the only amplicons, the system also adds an extra level of specificity to melting curve analysis.

MeltPlex® is covered by patent applications by Anapa Biotech and is available for licensing.

 

Please contact Anapa Biotech for more information:

CEO Søren Morgenthaler Echwald, + 45 2264 4916, This email address is being protected from spambots. You need JavaScript enabled to view it.

 

ABOUT ANAPA BIOTECH

Anapa Biotech A/S, former QuantiBact A/S, develops molecular tools to enhance the performance of natural nucleic acids in PCR based assays as well as hybridization. Our technology offers improvement to areas like human and veterinary diagnostics, food and feed quality and safety, environmental surveillance and general scientific research. For more information, visit the new website at www.anapabiotech.com.

Read more...

Meet us at The 4BIO Summit in London

At the qPCR & Digital Congress Anapa Biotech will present a poster entitled "MeltPlex multiplex PCR" at position q8. The poster presentation describes the design of MeltPlex® probes targeting 17 different hemorrhagic fever viruses in a single PCR tube and the results of testing against artificial DNA targets.

Read more...

Anapa Biotech presents MeltPlex® - a new multiplexing technology at QPCR 2017

Anapa Biotech has developed the MeltPlex® technology that utilizes a system of labelled Taqman-type probes allowing each to be read out by subsequent melting curve analysis. 5 or more probes can now be analyzed per fluorophore channel totaling more than 20 targets per single tube. We present MeltPlex® for the first time at QPCR 2017 in Freising-Weihenstephan, Germany.

Read more...